Top Tweets for #MARCAP

over 3 years ago

The benefit of ADT treatment intensification with radiotherapy in localized #ProstateCancer. @DrSpratticus @cwru and @AmarUKishan @UCLA discuss a @TheLancetOncol publication on behalf of the #MARCAP Consortium. #WatchNow on UroToday > https://t.co/0JyghL6J99

urotoday's tweet photo. The benefit of ADT treatment intensification with radiotherapy in localized #ProstateCancer. @DrSpratticus @cwru and @AmarUKishan @UCLA discuss a @TheLancetOncol publication on behalf of the #MARCAP Consortium. #WatchNow on UroToday > https://t.co/0JyghL6J99 https://t.co/qAACLuC53V

0

12

4

3K

over 3 years ago

The benefit of ADT treatment intensification with radiotherapy in localized #ProstateCancer. @DrSpratticus @cwru and @AmarUKishan @UCLA discuss a @TheLancetOncol publication on behalf of the #MARCAP Consortium. #WatchNow on UroToday > https://t.co/0JyghL7gYH

0

2

0

2K

Himanshu Nagar

@HimanshuNagarMD

over 3 years ago

@TylerSbrt @AmarUKishan @PCaParker @PaulSargos @jgong15 @ASCO @DrSpratticus @CSCancerCare @DrRanaMcKay @CParkMD @UCSDCancer @NazliDizman @crisbergerot @jacobadashek @urotoday @CancerNetwrk We definitely need biomarker selection prior to adopting 24 months in salvage setting for everyone. We just learned that X months of ADT suppression is much greater than X months. #MARCAP

HimanshuNagarMD's tweet photo. @TylerSbrt @AmarUKishan @PCaParker @PaulSargos @jgong15 @ASCO @DrSpratticus @CSCancerCare @DrRanaMcKay @CParkMD @UCSDCancer @NazliDizman @crisbergerot @jacobadashek @urotoday @CancerNetwrk We definitely need biomarker selection prior to adopting 24 months in salvage setting for everyone. We just learned that X months of ADT suppression is much greater than X months. #MARCAP https://t.co/L30FmYnrF3

0

3

2

0

329

Wee Loon Ong @weeloonong

over 3 years ago

presenting 2 posters at @ASCO #GU23 thanks to mentoring by @DrAndrewLoblaw @AmarUKishan 🙏 #2SMART trial 26Gy/2fx prostate SBRT + 32Gy boost @Sunnybrook @UofTDRO #MARCAP TRANSPORT meta-analyses @TROGfightcancer very humbled to be awarded @ASCO @ConquerCancerFd Merit Award

weeloonong's tweet photo. presenting 2 posters at @ASCO #GU23
thanks to mentoring by @DrAndrewLoblaw @AmarUKishan 🙏

#2SMART trial 26Gy/2fx prostate SBRT + 32Gy boost @Sunnybrook @UofTDRO

#MARCAP TRANSPORT meta-analyses @TROGfightcancer

very humbled to be awarded @ASCO @ConquerCancerFd Merit Award https://t.co/7gF9UybZEP

5

38

7

3

4K

over 3 years ago

The benefit of ADT treatment intensification with radiotherapy in localized #ProstateCancer. @DrSpratticus @cwru and @AmarUKishan @UCLA discuss a @TheLancetOncol publication on behalf of the #MARCAP Consortium. #WatchNow on UroToday > https://t.co/0JyghL6J99

0

7

1

0

1K

over 3 years ago

The benefit of ADT treatment intensification with radiotherapy in localized #ProstateCancer. @DrSpratticus @cwru and @AmarUKishan @UCLA discuss a @TheLancetOncol publication on behalf of the #MARCAP Consortium. #WatchNow on UroToday > https://t.co/0JyghL6J99

0

21

7

4

3K

over 3 years ago

The benefit of ADT treatment intensification with radiotherapy in localized #ProstateCancer. @DrSpratticus @cwru and @AmarUKishan @UCLA discuss a @TheLancetOncol publication on behalf of the #MARCAP Consortium. #WatchNow on UroToday > https://t.co/0JyghL6J99

0

15

2

4

2K

over 3 years ago

And he covered @AmarUKishan and Dr. Ma’s work on sequencing of ADT as well @NicholasZaorsky work on duration of ADT. #MARCAP

DrSpratticus's tweet photo. And he covered @AmarUKishan and Dr. Ma’s work on sequencing of ADT as well @NicholasZaorsky work on duration of ADT.

#MARCAP https://t.co/djBgnDIKVd

1

12

1

0

RadOncUH @RadOncUH

almost 4 years ago

Our very own @NicholasZaorsky presenting new data on the optimal duration of ADT with RT. #MARCAP @DrSpratticus @AmarUKishan

almost 4 years ago

@NicholasZaorsky knocking it out of the park #ASTRO22 ! Incredible MARCAP study showing optimal duration of ADT with most of the compliance data from the LT-ADT trials. Representing @RadoncUh on the big stage!

DrSpratticus's tweet photo. @NicholasZaorsky knocking it out of the park #ASTRO22 ! Incredible MARCAP study showing optimal duration of ADT with most of the compliance data from the LT-ADT trials.

Representing @RadoncUh on the big stage! https://t.co/pQxshIDLrh

5

83

18

5

0

9

1

0

almost 4 years ago

Amazing to finally catch-up with @AmarUKishan, my partner in crime for #MARCAP Consortium. So much accomplished and even more still to tackle. #ASTRO22

DrSpratticus's tweet photo. Amazing to finally catch-up with @AmarUKishan, my partner in crime for #MARCAP Consortium.

So much accomplished and even more still to tackle. #ASTRO22 https://t.co/VJMIEqlcNs

2

77

2

0

almost 4 years ago

So happy to see the years of hard work to pull the team and data together continues to provide fruitful and high impact results. Nice to see validation of our prior JCO paper with @SouMyajiT_RO that neoadj ADT inferior to concurrent/adjuvant. #MARCAP @RadoncUh @#astro22

Amar Kishan

@AmarUKishan

almost 4 years ago

Very pleased to present the 4th MARCAP analysis, "SANDSTORM" now live online at https://t.co/gZRVcpiezp @JCO_ASCO (1/n)

7

107

37

20

0

16

4

1

0